The Cost-Effectiveness of Hyperlipidemia Medication in Low- and Middle-Income Countries: A Review

Hyperlipidemia is a risk factor for cardiovascular disease – the leading cause of death globally. Increased understanding of the cost-effectiveness of hyperlipidemia treatment in low- and middle-income countries can guide approaches to hyperlipidemia management in resource-limited environments. We c...

Descripción completa

Detalles Bibliográficos
Autores principales: Husain, Muhammad Jami, Spencer, Garrison, Nugent, Rachel, Kostova, Deliana, Richter, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896253/
https://www.ncbi.nlm.nih.gov/pubmed/35342693
http://dx.doi.org/10.5334/gh.1097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896253/
https://www.ncbi.nlm.nih.gov/pubmed/35342693
http://dx.doi.org/10.5334/gh.1097

Ejemplares similares